Clinical Study Results
What adverse reactions did the participants have during the study?
This section is a summary of the adverse events the participants had during the study
that the study doctors thought might be related to the study drug. These medical
problems are called “adverse reactions”. An adverse reaction is considered “serious”
when it is life-threatening, causes lasting problems, or requires hospital care.
These adverse reactions may or may not be caused by the study drug. A lot of
research is needed to know whether a drug causes an adverse reaction.
The websites listed at the end of this summary may have other information about
adverse reactions or other medical problems that happened during this study.
How many participants had serious adverse reactions?
None of the participants had serious adverse reactions during the study.
How many participants had adverse reactions?
There were 5.6% of participants who took AZD9977 who had adverse reactions
during the study. This was 1 out of 18 participants.
There were 22.2% of participants who took the placebo who had adverse reactions
during the study. This was 2 out of 9 participants.
None of the participants stopped treatment because of adverse reactions they had
during the study.
The table below shows how many participants had adverse reactions during the study.
Adverse reactions during the study
AZD9977 50 mg AZD9977 150 mg AZD9977 300 mg Placebo
(out of 6 (out of 6 (out of 6 (out of 9
participants) participants) participants) participants)
How many participants had
adverse reactions during the 16.7% (1) 0.0% (0) 0.0% (0) 22.2% (2)
study?
How many participants had
serious adverse reactions 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
during the study?
How many participants
stopped treatment because 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0)
of adverse reactions?
6